Published in Heart Fail Clin on April 01, 2005
Targeting myocardial substrate metabolism in heart failure: potential for new therapies. Eur J Heart Fail (2012) 1.36
Novel and potential future biomarkers for assessment of the severity and prognosis of chronic heart failure : a clinical review. Heart Fail Rev (2006) 0.79
Potential autonomic nervous system effects of statins in heart failure. Heart Fail Clin (2008) 0.78
Central nervous system changes in pediatric heart failure: a volumetric study. Pediatr Cardiol (2010) 0.78
The genetics of congestive heart failure. Heart Fail Clin (2010) 0.76
Evaluation study of congestive heart failure and pulmonary artery catheterization effectiveness: the ESCAPE trial. JAMA (2005) 6.10
Importance of venous congestion for worsening of renal function in advanced decompensated heart failure. J Am Coll Cardiol (2009) 5.76
Nitroprusside in critically ill patients with left ventricular dysfunction and aortic stenosis. N Engl J Med (2003) 4.61
Heart failure, chronic diuretic use, and increase in mortality and hospitalization: an observational study using propensity score methods. Eur Heart J (2006) 4.55
Plasma B-type natriuretic peptide levels in ambulatory patients with established chronic symptomatic systolic heart failure. Circulation (2003) 4.25
Decision making in advanced heart failure: a scientific statement from the American Heart Association. Circulation (2012) 3.61
Spironolactone in chronic heart failure:all's well that ends well. J Am Coll Cardiol (2003) 2.47
Sodium nitroprusside for advanced low-output heart failure. J Am Coll Cardiol (2008) 2.47
2012 ACCF/AATS/SCAI/STS expert consensus document on transcatheter aortic valve replacement. J Am Coll Cardiol (2012) 2.44
Animal models of heart failure: a scientific statement from the American Heart Association. Circ Res (2012) 2.31
Aspirin and clopidogrel in acute coronary syndromes: therapeutic insights from the CURE study. Arch Intern Med (2003) 2.29
A new, precise definition of acute myocardial infarction. Cleve Clin J Med (2009) 2.18
Practicing 'check the box' medicine. Am J Med (2013) 2.00
Characterization and prognostic value of persistent hyponatremia in patients with severe heart failure in the ESCAPE Trial. Arch Intern Med (2007) 1.98
Detection of soluble angiotensin-converting enzyme 2 in heart failure: insights into the endogenous counter-regulatory pathway of the renin-angiotensin-aldosterone system. J Am Coll Cardiol (2008) 1.95
Evaluation and long-term prognosis of new-onset, transient, and persistent anemia in ambulatory patients with chronic heart failure. J Am Coll Cardiol (2008) 1.95
Elevated intra-abdominal pressure in acute decompensated heart failure: a potential contributor to worsening renal function? J Am Coll Cardiol (2008) 1.87
Acute heart failure syndromes: emergency department presentation, treatment, and disposition: current approaches and future aims: a scientific statement from the American Heart Association. Circulation (2010) 1.84
Fluid retention after initiation of thiazolidinedione therapy in diabetic patients with established chronic heart failure. J Am Coll Cardiol (2003) 1.70
Enhanced external counterpulsation improves exercise tolerance in patients with chronic heart failure. J Am Coll Cardiol (2006) 1.69
BNP Consensus Panel 2004: A clinical approach for the diagnostic, prognostic, screening, treatment monitoring, and therapeutic roles of natriuretic peptides in cardiovascular diseases. Congest Heart Fail (2004) 1.66
Neurohormonal response to left ventricular reconstruction surgery in ischemic cardiomyopathy. J Thorac Cardiovasc Surg (2004) 1.63
Cardiac troponins in renal insufficiency: review and clinical implications. J Am Coll Cardiol (2002) 1.63
Racial analysis of patients with myocardial infarction complicated by heart failure and/or left ventricular dysfunction treated with valsartan, captopril, or both. J Am Coll Cardiol (2008) 1.48
Advanced heart failure and transplant cardiology: a subspecialty is born. J Am Coll Cardiol (2009) 1.48
National Academy of Clinical Biochemistry Laboratory Medicine practice guidelines: Clinical utilization of cardiac biomarker testing in heart failure. Circulation (2007) 1.39
The prognostic value of estimated creatinine clearance alongside functional capacity in ambulatory patients with chronic congestive heart failure. J Am Coll Cardiol (2002) 1.34
Newly diagnosed and previously known diabetes mellitus and 1-year outcomes of acute myocardial infarction: the VALsartan In Acute myocardial iNfarcTion (VALIANT) trial. Circulation (2004) 1.33
Pathophysiologic targets in the early phase of acute heart failure syndromes. Am J Cardiol (2005) 1.27
ST-segment elevation myocardial infarction: recommendations on triage of patients to heart attack centers: is it time for a national policy for the treatment of ST-segment elevation myocardial infarction? J Am Coll Cardiol (2006) 1.24
Predictors of mortality in patients with heart failure and preserved systolic function in the Digitalis Investigation Group trial. J Am Coll Cardiol (2004) 1.23
Impact of myocardial function on cystatin C measurements in chronic systolic heart failure. J Card Fail (2008) 1.18
Plasma B-type natriuretic peptide levels predict postoperative atrial fibrillation in patients undergoing cardiac surgery. Circulation (2004) 1.17
Recommendations for the use of mechanical circulatory support: device strategies and patient selection: a scientific statement from the American Heart Association. Circulation (2012) 1.16
ACC/AHA guidelines for the evaluation and management of chronic heart failure in the adult: executive summary. J Heart Lung Transplant (2002) 1.16
Predictors of the first heart failure hospitalization in patients who are stable survivors of myocardial infarction complicated by pulmonary congestion and/or left ventricular dysfunction: a VALIANT study. Eur Heart J (2008) 1.15
Soluble angiotensin-converting enzyme 2 in human heart failure: relation with myocardial function and clinical outcomes. J Card Fail (2009) 1.04
Usefulness of Isosorbide Dinitrate and Hydralazine as add-on therapy in patients discharged for advanced decompensated heart failure. Am J Cardiol (2009) 0.99
An international perspective on heart failure and left ventricular systolic dysfunction complicating myocardial infarction: the VALIANT registry. Eur Heart J (2004) 0.98
Statin treatment for patients with heart failure. Nat Rev Cardiol (2010) 0.94
National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines: clinical utilization of cardiac biomarker testing in heart failure. Clin Biochem (2007) 0.93
ACCF/AHA/ACP/HFSA/ISHLT 2010 clinical competence statement on management of patients with advanced heart failure and cardiac transplant: a report of the ACCF/AHA/ACP Task Force on Clinical Competence and Training. J Am Coll Cardiol (2010) 0.93
Prognostic evaluation of ambulatory patients with advanced heart failure. Am J Cardiol (2008) 0.93
Prompt reduction in intra-abdominal pressure following large-volume mechanical fluid removal improves renal insufficiency in refractory decompensated heart failure. J Card Fail (2008) 0.92
Comparative sensitivities between different plasma B-type natriuretic peptide assays in patients with minimally symptomatic heart failure. Clin Cornerstone (2005) 0.91
Treating heart failure with enhanced external counterpulsation (EECP): design of the Prospective Evaluation of EECP in Heart Failure (PEECH) trial. J Card Fail (2005) 0.89
Testing for B-type natriuretic peptide in the diagnosis and assessment of heart failure: what are the nuances? Cleve Clin J Med (2004) 0.89
Heart failure therapy at a crossroad: are there limits to the neurohormonal model? J Am Coll Cardiol (2003) 0.89
Outcomes of patients with stable heart failure undergoing elective noncardiac surgery. Mayo Clin Proc (2008) 0.87
ACCF/AHA/ACP/HFSA/ISHLT 2010 clinical competence statement on management of patients with advanced heart failure and cardiac transplant: a report of the ACCF/AHA/ACP Task Force on Clinical Competence and Training. Circulation (2010) 0.86
Autologous cell transplantation for the treatment of damaged myocardium. Prog Cardiovasc Dis (2002) 0.85
Adverse drug reactions in patients with cardiovascular disease. Curr Probl Cardiol (2008) 0.84
Why do patients fail to receive beta-blockers for chronic heart failure over time? A "real-world" single-center, 2-year follow-up experience of beta-blocker therapy in patients with chronic heart failure. Am Heart J (2005) 0.84
Enhanced external counterpulsation improves exercise duration and peak oxygen consumption in older patients with heart failure: a subgroup analysis of the PEECH trial. Congest Heart Fail (2006) 0.83
The year in heart failure. J Am Coll Cardiol (2008) 0.83
Catheter ablation of hemodynamically unstable ventricular tachycardia with mechanical circulatory support. Int J Cardiol (2013) 0.82
Beta-blockers and reverse remodeling: what are the implications? Am Heart J (2003) 0.82
Gender differences in patients admitted with advanced decompensated heart failure. Am J Cardiol (2008) 0.81
Aldosterone receptor antagonists in the medical management of chronic heart failure. Mayo Clin Proc (2005) 0.81
Phosphodiesterase 5 inhibition in heart failure: mechanisms and clinical implications. Nat Rev Cardiol (2009) 0.81
Anemia and heart failure a new pathway? J Am Coll Cardiol (2007) 0.80
Contractile reserve: are we beginning to understand it? JACC Cardiovasc Imaging (2008) 0.80
Combining neuroendocrine inhibitors in heart failure: reflections on safety and efficacy. Am J Med (2007) 0.80
Current Diagnostic and Treatment Strategies for Specific Dilated Cardiomyopathies: A Scientific Statement From the American Heart Association. Circulation (2016) 0.80
Contemporary management and research directions in advanced heart failure: where are we going? Congest Heart Fail (2011) 0.79
Histamine, mast cells, and heart failure: is there a connection? J Am Coll Cardiol (2006) 0.79
Heart rate response during dipyridamole stress as a predictor of mortality in patients with normal myocardial perfusion and normal electrocardiograms. Am J Cardiol (2005) 0.79
Highlights of the 2006 scientific sessions of the Heart Failure Society of America: Seattle, Washington, September 10-13, 2006. J Am Coll Cardiol (2007) 0.78
Early cardiac resynchronization therapy and reverse remodeling in patients with mild heart failure: is it time? Circulation (2009) 0.78
Notice of concern. J Card Fail (2013) 0.78
Should we consider aldosterone as the primary screening target for preventing cardiovascular events? J Am Coll Cardiol (2005) 0.77
From B-type natriuretic peptide to green mambas: the process of discovery. J Am Coll Cardiol (2008) 0.77
Induction and maintenance of an experimental model of severe cardiomyopathy with a novel protocol of rapid ventricular pacing. J Thorac Cardiovasc Surg (2002) 0.77
ALLogeneic Heart STem Cells to Achieve Myocardial Regeneration (ALLSTAR) Trial: Rationale and Design. Cell Transplant (2016) 0.77
Cardiac resynchronization therapy in New York Heart Association class IV heart failure: it is all about selection. Circulation (2007) 0.77
A hard look at angiotensin receptor blockers in heart failure. J Am Coll Cardiol (2004) 0.77
Drug insight: aldosterone-receptor antagonists in heart failure--the journey continues. Nat Clin Pract Cardiovasc Med (2007) 0.76
Management of heart failure: a brief review and selected update. Cardiol Clin (2008) 0.76
Atrial fibrillation and heart failure: intersecting populations, morbidities, and mortality. Heart Fail Rev (2014) 0.76
Effect of Angiotensin-converting enzyme inhibitors and Angiotensin receptor antagonists in atherosclerosis prevention. Curr Cardiol Rep (2012) 0.76
Advanced heart failure and transplant cardiology: a subspecialty is born. J Card Fail (2009) 0.76
Nuggets, pearls, and vignettes of master heart failure clinicians. Part 4--treatment. Congest Heart Fail (2002) 0.75
Cardiac resynchronization therapy in patients with class I-II heart failure and a wide QRS: a cautionary note. Circulation (2011) 0.75
Effects of sodium nitroprusside in aortic stenosis associated with severe heart failure: pressure-volume loop analysis using a numerical model. Am J Physiol Heart Circ Physiol (2004) 0.75
Angiotensin-converting enzyme inhibitors and angiotensin-receptor blockers in chronic heart failure. Ann Intern Med (2005) 0.75
Vasopressin receptor antagonists: will the "vaptans" fulfill their promise? JAMA (2004) 0.75
Exploring new drugs for heart failure: the case of urocortin. Eur Heart J (2007) 0.75
Reply: applying cluster analysis to data of previously published chronic heart failure trials. J Am Coll Cardiol (2015) 0.75
It is all about heart rate. Or is it? J Am Coll Cardiol (2012) 0.75
The difficult task of evaluating how to monitor patients with heart failure. J Card Fail (2005) 0.75
How important is it to drink eight glasses of water every day? I try to do that, but often am able to get only about six glasses in. Heart Advis (2002) 0.75